ENVOYER
LIVE

Serial Number

98376228

Owner

Envoya Inc.

Attorney

Susan G. L. Glovsky

First Use Date

Aug 20, 2024

Filing Date

Jan 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENVOYER Trademark

Serial Number: 98376228 • Registration: 8096742

ENVOYER is a trademark filed by Envoya Inc. on January 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Envoya Inc. (2 trademarks)

157 Winthrop Road
Brookline, MA 02445

Entity Type: 03

Trademark Details

Filing Date

January 25, 2024

Registration Date

January 6, 2026

First Use Anywhere

August 20, 2024

First Use in Commerce

August 20, 2024

Published for Opposition

November 12, 2024

Goods & Services

Gene therapy products, namely, non-lipid polymer based nanoparticles for gene therapy; gene therapy products, namely polymer-based nanoparticles for medical, veterinary and pharmaceutical purposes; nucleic acid-containing products, namely RNA and DNA, for medical or veterinary purposes; gene therapy products for the treatment of cancer, metabolic diseases or disorders, neurodegenerative diseases or disorders, cardiovascular diseases or disorders, infectious diseases, or inflammatory diseases or disorders, namely, non-viral vectors; nanoparticle products for medical or veterinary purposes, namely, non-viral vectors; nanoparticles for medical or veterinary purposes, namely, stabilized non-lipid polymer based nanoparticles; nanoparticles that encapsulate nucleic acids for medical or veterinary purposes; nanoparticles that encapsulate cytotoxic payloads in cells for medical or veterinary purposes

Pharmaceutical research and development; research and development services in the field of pharmaceuticals; gene therapy research and development services; research and development services relating to the delivery of RNA and DNA therapeutics to patients; research and development services in the field of nanoparticles and microparticles; research and development services in the field of nucleic acid-containing particles; research and development services in the field of nucleic acids, proteins, and small molecules delivery; Development of nucleic acids, namely RNA and DNA, for encapsulating nanoparticles for targeted delivery; Research services in the field of nanoparticle characteristics; Research services in the field of microparticle characteristics; research and development services in the field of pharmaceutical preparations for the treatment of disease or disorders; research and development services in the field of pharmaceutical preparations for the treatment of cancer, muscular dystrophy, metabolic diseases or disorders, neurodegenerative diseases or disorders, cardiovascular diseases or disorders, infectious diseases, inflammatory diseases or disorders, rare diseases; scientific and technological services, namely, scientific research, analysis, testing, treatment optimizations in the field of nucleic acids, proteins, and small molecules delivery to human cells; scientific and technological services, namely, scientific research, analysis, testing, treatment optimizations in the field of protein delivery to human cells; Scientific and technological services, namely, research and design relating to scientific and technological services in the field of nucleic acids, proteins, and small molecules therapeutics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 15, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 15, 2025 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2025 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Dec 10, 2025 SUPC
SOU EXTENSION 1 GRANTED
Dec 10, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 10, 2025 AITU
ASSIGNED TO EXAMINER
Aug 25, 2025 DOCK
SOU EXTENSION 1 FILED
Jun 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 24, 2025 EEXT
USE AMENDMENT FILED
Apr 15, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 15, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2024 NWOS
NEW APPLICATION ENTERED
Jan 25, 2024 NWAP